Skip to main content
. 2012 Nov 9;12:214. doi: 10.1186/1472-6882-12-214

Figure 6.

Figure 6

Anti-dengue effect of continuous treatment with baicalein. Foci forming unit reduction assay was used to evaluate the in vitro anti-dengue virus activities of the baicalein (A). The respective DENV-2 RNA copy number was quantified using qRT-PCR (B). The percentages of foci reduction (%RF) and RNA copy number reduction were obtained by comparing against untreated controls maintained in parallel.